-transparent.png){kind=logo}
Combination therapy, using drugs from different classes of oral hypoglycemic agents, offers several advantages in the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Appropriate combinations can significantly improve glycemia and often obviate insulin treatment. In general, no increased toxicity or significant interactions are observed.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
L A Leiter
July 1993,
The Nurse practitioner,
L A Leiter
January 1997,
Irish journal of medical science,
L A Leiter
July 1995,
The Nurse practitioner,
L A Leiter
October 1985,
Archives of internal medicine,
L A Leiter
January 1998,
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
L A Leiter
November 1991,
Connecticut medicine,
L A Leiter
January 1998,
Annals of nutrition & metabolism,
L A Leiter
May 1987,
Postgraduate medicine,
L A Leiter
January 1995,
The National medical journal of India,
L A Leiter
May 1988,
Bailliere's clinical endocrinology and metabolism,
